The Office of AIDS Research (OAR), the coordinating body of the HIV/AIDS research agenda and priority-setting entity at the National Institutes of Health (NIH), is sponsoring the “ Access, Delivery, Engagement, and Retention for Long-Acting HIV Prevention and Treatment in the United States ” Challenge (LAUNCH Challenge) to encourage and reward innovative ideas to address persistent, well-documented barriers to the implementation and scale up of HIV prevention and treatment interventions. The LAUNCH Challenge is one opportunity to foster and reward innovation in HIV implementation science under an umbrella program recently launched by OAR, called Advancing Research in Implementation Science to End HIV (ARISE-HIV).
This competition solicits innovative and actionable ideas to address challenges and constraints associated with the prevention of HIV transmission, and HIV treatment, through uptake of LA antiretroviral products. This competition will prioritize the rewarding of ideas that propose creative solutions, pragmatic approaches, and novel implementation strategies to address these challenges. The Challenge is offering a total prize purse of $1 million dollars across two phases. Prizes will be awarded to teams who submit the most compelling ideas (Phase 1) and related implementation and evaluation plans (Phase 2).
Phase 1 Submission Final Due date: August 6, 2026 , 5:00PM EDT
Ideas from a large range of submitters are welcome, including individuals or teams of individuals, community-based organizations, academia, industry, and teams across multiple organizations and sectors. Submissions from individuals or organizations not currently funded by NIH are encouraged.
Sponsor Institute/Organizations: National Institutes of Health
Sponsor Type: Government/Federal
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Aug 06, 2026
Aug 06, 2026
Varies
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Website URL: https://grants.nih.gov/grants/guide/notice-files/NOT-AA-24-007.html
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.